Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | GI50 | > 100 μM | Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 32345458] |
| BV-2 | IC50 | 47.1 μM | Anti-inflammatory in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production pre-incubated before LPS challenge for 24 hrs by Griess reagent based assay | [PMID: 28358502] |
| CCRF-CEM | IC50 | 3.27 μM | Cytotoxicity against human CEM cells after 48 hrs | [PMID: 20873721] |
| H9 | EC50 | 4 μg/mL | Cytotoxicity against mock-infected human H9 cells after 4 days | [PMID: 9748372] |
| H9 | IC50 | 8 μg/mL | Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA | [PMID: 9748372] |
| HCT-116 | GI50 | > 100 μM | Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 32345458] |
| HEK293 | IC50 | 0.81 μM | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as reduction of cortisone to cortisol conversion by scintillation counting | [PMID: 20100662] |
| HepG2 | IC50 | > 10 μM | Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay | [PMID: 27797185] |
| HT-29 | IC50 | > 10 μM | Cytotoxicity against human HT-29 cells after 48 hrs | [PMID: 20873721] |
| MCF7 | IC50 | > 10 μM | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | [PMID: 27797185] |
| MCF7 | IC50 | > 10 μM | Cytotoxicity against human MCF7 cells after 48 hrs | [PMID: 20873721] |
| MCF7 | GI50 | 18.5 μM | Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay | [PMID: 28754470] |
| MCF7 | GI50 | 62 μM | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 32345458] |
| MDA-MB-231 | GI50 | 15.3 μM | Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay | [PMID: 28754470] |
| NCI-H460 | IC50 | > 10 μM | Cytotoxicity against human NCI-H460 cells after 48 hrs | [PMID: 20873721] |
| NCI-N87 | IC50 | 4.4 μM | Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay | [PMID: 27797185] |
| Sf21 | IC50 | > 40 μM | Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis | [PMID: 31774676] |
| SK-OV-3 | IC50 | 10.51 μM | Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay | [PMID: 35500202] |
| SK-OV-3 | IC50 | 26.42 μM | Reversal of platinum resistance in cisplatin-resistant human SK-OV-3 cells assessed as reduction in cisplatin IC50 after 48 hrs in presence of cisplatin by SRB assay (Rvb = 28.23 microM) | [PMID: 35500202] |
19 records · Scroll to view more